Results for tag: "Clostridium Difficile Drug"

Clostridium Difficile (C. Difficile) is a type of bacteria that can cause severe diarrhea and other intestinal problems. It is a major cause of infectious diseases, and is particularly common in hospitals and nursing homes. Treatment for C. Difficile typically involves antibiotics, and the C. Difficile Drug market is focused on developing and marketing drugs to treat this infection. The C. Difficile Drug market is highly competitive, with many companies developing and marketing drugs to treat this infection. These drugs are typically used in combination with other treatments, such as probiotics, to reduce the risk of recurrence. Companies in the C. Difficile Drug market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more